ECRI Researcher Greg Pond receives an OICR Level II Award. Click here for more details:
A Hamilton patient is the first trial participant to receive a novel experimental immunotherapy for lung cancer.
McMaster breast cancer specialist appointed to the Order of Canada
Feel free to call, send us an email, Tweet us or use our contact form
© 2014 - Escarpment Cancer Research Institute
Built by factor[e].
Powered by Forge.